Lori A. Orlando

3.5k total citations
80 papers, 1.8k citations indexed

About

Lori A. Orlando is a scholar working on Genetics, Oncology and Economics and Econometrics. According to data from OpenAlex, Lori A. Orlando has authored 80 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 17 papers in Oncology and 15 papers in Economics and Econometrics. Recurrent topics in Lori A. Orlando's work include BRCA gene mutations in cancer (31 papers), Genomics and Rare Diseases (20 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Lori A. Orlando is often cited by papers focused on BRCA gene mutations in cancer (31 papers), Genomics and Rare Diseases (20 papers) and Health Systems, Economic Evaluations, Quality of Life (13 papers). Lori A. Orlando collaborates with scholars based in United States, Singapore and United Kingdom. Lori A. Orlando's co-authors include Geoffrey S. Ginsburg, David B. Matchar, R. Ryanne Wu, Roy C. Orlando, Vincent C. Henrich, Douglas C McCrory, Rebecca N Gray, Richard C. Mather, Adam H. Buchanan and Elizabeth R. Hauser and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Lori A. Orlando

77 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori A. Orlando United States 26 549 345 249 240 233 80 1.8k
Arrigo Schieppati Italy 34 475 0.9× 360 1.0× 261 1.0× 77 0.3× 534 2.3× 75 4.2k
Rita Schinnar United States 21 302 0.6× 318 0.9× 379 1.5× 206 0.9× 170 0.7× 36 2.5k
Lilly Q. Yue United States 17 117 0.2× 230 0.7× 181 0.7× 183 0.8× 137 0.6× 43 2.3k
Andrea O. Y. Luk Hong Kong 33 533 1.0× 642 1.9× 211 0.8× 154 0.6× 569 2.4× 188 4.2k
Alexander Thompson United Kingdom 19 218 0.4× 1.0k 2.9× 165 0.7× 91 0.4× 672 2.9× 51 2.6k
Susanne B. Nicholas United States 30 181 0.3× 323 0.9× 190 0.8× 107 0.4× 509 2.2× 87 2.8k
Clare Oliver‐Williams United Kingdom 24 528 1.0× 729 2.1× 537 2.2× 132 0.6× 708 3.0× 49 3.2k
Elvira D’Andrea United States 22 257 0.5× 145 0.4× 121 0.5× 155 0.6× 68 0.3× 62 1.1k
Eric S. H. Lau Hong Kong 26 337 0.6× 323 0.9× 197 0.8× 83 0.3× 282 1.2× 109 2.2k
April W. Armstrong United States 29 156 0.3× 147 0.4× 100 0.4× 181 0.8× 74 0.3× 80 3.4k

Countries citing papers authored by Lori A. Orlando

Since Specialization
Citations

This map shows the geographic impact of Lori A. Orlando's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori A. Orlando with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori A. Orlando more than expected).

Fields of papers citing papers by Lori A. Orlando

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori A. Orlando. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori A. Orlando. The network helps show where Lori A. Orlando may publish in the future.

Co-authorship network of co-authors of Lori A. Orlando

This figure shows the co-authorship network connecting the top 25 collaborators of Lori A. Orlando. A scholar is included among the top collaborators of Lori A. Orlando based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori A. Orlando. Lori A. Orlando is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hertz, Daniel L., Chad Bousman, Howard L. McLeod, et al.. (2024). Recommendations for pharmacogenetic testing in clinical practice guidelines in the US. American Journal of Health-System Pharmacy. 81(16). 672–683. 8 indexed citations
2.
Haga, Susanne B. & Lori A. Orlando. (2023). Expanding Family Health History to Include Family Medication History. Journal of Personalized Medicine. 13(3). 410–410. 1 indexed citations
3.
Bland, Harris T., Marian J. Gilmore, Gillian W. Hooker, et al.. (2023). Conducting inclusive research in genetics for transgender, gender‐diverse, and sex‐diverse individuals: Case analyses and recommendations from a clinical genomics study. Journal of Genetic Counseling. 33(4). 772–785. 5 indexed citations
4.
5.
Voils, Corrine I., Cynthia J. Coffman, R. Ryanne Wu, et al.. (2022). A Cluster Randomized Trial of a Family Health History Platform to Identify and Manage Patients at Increased Risk for Colorectal Cancer. Journal of General Internal Medicine. 38(6). 1375–1383. 4 indexed citations
6.
Chung, Wendy K., Kyle B. Brothers, Angela R. Bradbury, et al.. (2021). Genomic medicine implementation protocols in the PhenX Toolkit: tools for standardized data collection. Genetics in Medicine. 23(9). 1783–1788. 2 indexed citations
7.
Whirl‐Carrillo, Michelle, Katrin Sangkuhl, Philip E. Empey, et al.. (2020). Variant Interpretation in Current Pharmacogenetic Testing. Journal of Personalized Medicine. 10(4). 204–204. 7 indexed citations
8.
Zebrowski, Alexis, Frances K. Barg, Nina Sperber, et al.. (2018). Qualitative study of system-level factors related to genomic implementation. Genetics in Medicine. 21(7). 1534–1540. 32 indexed citations
9.
Levy, Kenneth D., Kathryn Blake, James P. Franciosi, et al.. (2018). Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network. Genetics in Medicine. 21(3). 743–747. 36 indexed citations
10.
Orlando, Lori A., Nina Sperber, Corrine I. Voils, et al.. (2017). Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network’s Common Measures Working Group. Genetics in Medicine. 20(6). 655–663. 49 indexed citations
11.
Phillips, Kathryn A., Patricia A. Deverka, Harold C. Sox, et al.. (2017). Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness research. Genetics in Medicine. 19(10). 1–11. 42 indexed citations
12.
Wu, R. Ryanne, Rachel A. Myers, Catherine A. McCarty, et al.. (2015). Protocol for the “Implementation, adoption, and utility of family history in diverse care settings” study. Implementation Science. 10(1). 163–163. 17 indexed citations
13.
Orlando, Lori A., R. Ryanne Wu, Christopher A. Beadles, et al.. (2014). Implementing family health history risk stratification in primary care: Impact of guideline criteria on populations and resource demand. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 166(1). 24–33. 37 indexed citations
14.
Beadles, Christopher A., R. Ryanne Wu, Tiffany Himmel, et al.. (2014). Providing patient education: impact on quantity and quality of family health history collection. Familial Cancer. 13(2). 325–332. 23 indexed citations
15.
Buchanan, Adam H., Carol A. Christianson, Tiffany Himmel, et al.. (2014). Use of a Patient‐Entered Family Health History Tool with Decision Support in Primary Care: Impact of Identification of Increased Risk Patients on Genetic Counseling Attendance. Journal of Genetic Counseling. 24(1). 179–188. 23 indexed citations
16.
Matchar, David B., Mugdha Thakur, Iris Grossman, et al.. (2007). Testing for cytochrome P450 polymorphisms in adults with non-psychotic depression treated with selective serotonin reuptake inhibitors (SSRIs).. PubMed. 1–77. 50 indexed citations
17.
Orlando, Lori A., William F. Owen, & David B. Matchar. (2007). Relationship between Nephrologist Care and Progression of Chronic Kidney Disease. North Carolina Medical Journal. 68(1). 9–16. 35 indexed citations
18.
Orlando, Lori A. & David B. Matchar. (2004). When to Stress Over Triptans: A Markov Analysis of Cardiovascular Risk in Migraine Treatment. Headache The Journal of Head and Face Pain. 44(7). 652–660. 4 indexed citations
19.
Orlando, Lori A., Shalini Kulasingam, & David B. Matchar. (2004). Meta‐analysis: the detection of pancreatic malignancy with positron emission tomography. Alimentary Pharmacology & Therapeutics. 20(10). 1063–1070. 46 indexed citations
20.
Orlando, Lori A., et al.. (1999). Frecuencia de alteraciones bucales tratadas quirúrgicamente. Revista Cubana de Estomatología. 36(2). 151–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arrigo Schieppati Breakdown of academic impact, for papers by Rita Schinnar Breakdown of academic impact, for papers by Lilly Q. Yue Breakdown of academic impact, for papers by Andrea O. Y. Luk Breakdown of academic impact, for papers by Alexander Thompson Breakdown of academic impact, for papers by Susanne B. Nicholas Breakdown of academic impact, for papers by Clare Oliver‐Williams Breakdown of academic impact, for papers by Elvira D’Andrea Breakdown of academic impact, for papers by Eric S. H. Lau Breakdown of academic impact, for papers by April W. Armstrong
Rankless by CCL
2026